Khalife N - Search Results

1

Futibatinib: new targeted therapy in intrahepatic cholangiocarcinoma.

Khoury R, Khalife N, Ibrahim R, Saleh K. Khoury R, et al. Among authors: khalife n. Hepatobiliary Surg Nutr. 2023 Dec 1;12(6):923-926. doi: 10.21037/hbsn-23-476. Epub 2023 Nov 15. Hepatobiliary Surg Nutr. 2023. PMID: 38115933 Free PMC article. No abstract available.

2

Late Recurrence of Low-Risk Stage II Colorectal Cancer Shortly After Etanercept.

Ibrahim T, Saleh K, Track-Smayra V, Ziade N, Sarraf D, Yazbeck C, Khalife N, Nasr F. Ibrahim T, et al. Among authors: khalife n. J Gastrointest Cancer. 2016 Dec;47(4):506-508. doi: 10.1007/s12029-015-9788-y. J Gastrointest Cancer. 2016. PMID: 26691174 No abstract available.

3

Febuxostat-associated eosinophilic polymyositis in marginal zone lymphoma.

Chahine G, Saleh K, Ghorra C, Khoury N, Khalife N, Fayad F. Chahine G, et al. Among authors: khalife n. Joint Bone Spine. 2017 Mar;84(2):221-223. doi: 10.1016/j.jbspin.2016.10.008. Epub 2016 Dec 7. Joint Bone Spine. 2017. PMID: 27955822

4

Chemotherapy-free regimen: a new hope in Philadelphia-positive acute lymphoblastic leukemia.

Saleh K, Chahine C, Khalife N. Saleh K, et al. Among authors: khalife n. Future Oncol. 2021 Apr;17(11):1265-1267. doi: 10.2217/fon-2020-1220. Epub 2021 Feb 12. Future Oncol. 2021. PMID: 33573414 No abstract available.

5

RET fusions in non-small-cell lung cancer: an emerging target reshaping the treatment paradigm.

Saleh K, Khalife N, Felefly T. Saleh K, et al. Among authors: khalife n. Future Oncol. 2021 Apr;17(12):1445-1448. doi: 10.2217/fon-2020-1297. Epub 2021 Feb 12. Future Oncol. 2021. PMID: 33573417 No abstract available.

6

Rearranged-in-transfection inhibitors: emerging agnostic targeted therapies for solid tumors.

Saleh K, Felefly T, Khalife N, Kourie HR. Saleh K, et al. Among authors: khalife n. Pharmacogenomics. 2021 Apr;22(5):247-250. doi: 10.2217/pgs-2021-0002. Epub 2021 Mar 23. Pharmacogenomics. 2021. PMID: 33754802 No abstract available.

7

Cemiplimab: a new option for the treatment of non-small-cell lung cancer.

Khalife N, Kordahi M, Felefly T, Saleh K. Khalife N, et al. Future Oncol. 2021 Jul;17(20):2559-2562. doi: 10.2217/fon-2021-0343. Epub 2021 May 28. Future Oncol. 2021. PMID: 34047193 No abstract available.

8

KRAS-targeted therapies in advanced solid cancers: drug the undruggable?

Saleh K, Kordahi M, Felefly T, Kourie HR, Khalife N. Saleh K, et al. Among authors: khalife n. Pharmacogenomics. 2021 Jul;22(10):587-590. doi: 10.2217/pgs-2021-0045. Epub 2021 Jun 21. Pharmacogenomics. 2021. PMID: 34148378 No abstract available.

9

Urothelial carcinoma in the era of immune checkpoint inhibitors.

Khalife N, Chahine C, Kordahi M, Felefly T, Kourie HR, Saleh K. Khalife N, et al. Immunotherapy. 2021 Aug;13(11):953-964. doi: 10.2217/imt-2021-0042. Epub 2021 Jun 29. Immunotherapy. 2021. PMID: 34184561 Review.

10

Efficacy and safety of immune checkpoint inhibitors in elderly patients (≥70 years) with squamous cell carcinoma of the head and neck.

Saleh K, Auperin A, Martin N, Borcoman E, Torossian N, Iacob M, Ferrand FR, Khalife N, Baste N, Guigay J, Le Tourneau C, Daste A, Saada-Bouzid E, Even C. Saleh K, et al. Among authors: khalife n. Eur J Cancer. 2021 Nov;157:190-197. doi: 10.1016/j.ejca.2021.08.030. Epub 2021 Sep 15. Eur J Cancer. 2021. PMID: 34536943

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters